Novare Capital Management’s AbbVie ABBV Stock Holding History

Novare Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.8M	Buy	58,300 +1,362	+2%	+$253K	0.88%	40
2025 Q1	$11.9M	Sell	56,938 -1,254	-2%	-$263K	1.04%	36
2024 Q4	$10.3M	Buy	58,192 +5,341	+10%	+$949K	0.87%	43
2024 Q3	$10.4M	Buy	52,851 +6,072	+13%	+$1.2M	0.88%	44
2024 Q2	$8.02M	Buy	46,779 +41,920	+863%	+$7.19M	0.72%	54
2024 Q1	$885K	Sell	4,859 -1,643	-25%	-$299K	0.08%	111
2023 Q4	$1.01M	Sell	6,502 -266	-4%	-$41.2K	0.1%	108
2023 Q3	$1.01M	Sell	6,768 -60	-0.9%	-$8.94K	0.11%	103
2023 Q2	$920K	Sell	6,828 -170	-2%	-$22.9K	0.1%	109
2023 Q1	$1.12M	Sell	6,998 -245	-3%	-$39K	0.13%	101
2022 Q4	$1.17M	Sell	7,243 -1,760	-20%	-$284K	0.14%	100
2022 Q3	$1.21M	Sell	9,003 -371	-4%	-$49.8K	0.15%	92
2022 Q2	$1.44M	Sell	9,374 -2,174	-19%	-$333K	0.18%	88
2022 Q1	$1.87M	Sell	11,548 -2,809	-20%	-$455K	0.2%	83
2021 Q4	$1.94M	Sell	14,357 -3,130	-18%	-$424K	0.2%	84
2021 Q3	$1.89M	Sell	17,487 -423	-2%	-$45.6K	0.21%	86
2021 Q2	$2.02M	Sell	17,910 -58,097	-76%	-$6.54M	0.23%	83
2021 Q1	$8.23M	Buy	76,007 +1,620	+2%	+$175K	0.99%	43
2020 Q4	$7.97M	Buy	74,387 +1,553	+2%	+$166K	1.04%	34
2020 Q3	$6.38M	Buy	72,834 +1,658	+2%	+$145K	0.9%	46
2020 Q2	$6.99M	Buy	71,176 +3,123	+5%	+$307K	1.05%	32
2020 Q1	$5.19M	Buy	68,053 +4,855	+8%	+$370K	0.91%	44
2019 Q4	$5.6M	Buy	63,198 +131	+0.2%	+$11.6K	0.78%	62
2019 Q3	$4.78M	Buy	63,067 +6,565	+12%	+$497K	0.71%	67
2019 Q2	$4.11M	Sell	56,502 -638	-1%	-$46.4K	0.63%	68
2019 Q1	$4.61M	Buy	57,140 +7,440	+15%	+$600K	0.72%	64
2018 Q4	$4.58M	Buy	49,700 +2,684	+6%	+$247K	0.84%	53
2018 Q3	$4.36M	Buy	47,016 +170	+0.4%	+$15.8K	0.7%	57
2018 Q2	$4.34M	Sell	46,846 -2,294	-5%	-$213K	0.74%	59
2018 Q1	$4.65M	Sell	49,140 -4,990	-9%	-$472K	0.81%	55
2017 Q4	$5.24M	Sell	54,130 -795	-1%	-$76.9K	0.89%	47
2017 Q3	$4.88M	Buy	+54,925	New	+$4.88M	0.86%	48